No. 25A514
Janssen Pharmaceuticals, Inc. v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Tags: compelled-speech fifth-amendment first-amendment government-coercion medicare-drug-negotiation takings-clause
Latest Conference:
N/A
Question Presented (from Petition)
Question not identified.
Question Presented (AI Summary)
Whether the Medicare Drug Price Negotiation Program's mandatory price negotiations and severe financial penalties for non-compliance constitute an unconstitutional taking or compelled speech in violation of the Fifth and First Amendments
Docket Entries
2025-11-05
Application (25A514) granted by Justice Sotomayor extending the time to file until December 19, 2025.
2025-10-31
Application (25A514) to extend the time to file a petition for a writ of certiorari from December 3, 2025 to December 19, 2025, submitted to Justice Alito.
2025-10-31
Application (25A514) to extend the time to file a petition for a writ of certiorari from December 3, 2025 to December 19, 2025, submitted to Justice Sotomayor. (Justice Alito is recused)
Attorneys
Janssen Pharmaceuticals Inc.
Kevin Franz King — Covington & Burling LLP, Petitioner
Robert F. Kennedy, Jr., in his official capacity as Secretary of Health & Human Services, et al.
D. John Sauer — Solicitor General, Respondent